Salutaxel, a Conjugate of Docetaxel and a Muramyl Dipeptide (MDP) Analogue, Acts as Multifunctional Prodrug That Inhibits Tumor Growth and Metastasis

Autor: Wen, Xiaoming, Zheng, Purong, Ma, Yao, Ou, Yingye, Huang, Weixin, Li, Shuo, Liu, Shoujia, Zhang, Xuan, Wang, Ziyu, Zhang, Qianli, Cheng, Wenming, Lin, Ruwen, Li, Hongzu, Cai, Youyou, Hu, Chunyun, Wu, Ningbin, Wan, Long, Pan, Tingting, Rao, Jinlong, Bei, Xuelu, Wu, Weibin, Jin, Jian, Yan, Jie, Liu, Gang
Zdroj: Journal of Medicinal Chemistry; 20240101, Issue: Preprints
Abstrakt: Salutaxel (3) is a conjugate of docetaxel (7) and a muramyl dipeptide (MDP) analogue. Docetaxel (7) has been recognized as a highly active chemotherapeutic agent against various cancers. MDP and its analogues are powerful potentiators of the antitumor actions of various tumor-necrotizing agents. This article documents the discovery of compound 3and presents pharmacological proof of its biological function in tumor-bearing mice. Drug candidate 3was superior to compound 7in its ability to prevent tumor growth and metastasis. Compound 3suppressed myeloid-derived suppressor cell (MDSC) accumulation in the spleens of tumor-bearing mice and decreased various serum inflammatory cytokines levels. Furthermore, compound 3antagonized the nucleotide-binding oligomerization domain-like receptor 1 (NOD1) signaling pathway both in vitro and in vivo.
Databáze: Supplemental Index